Literature DB >> 25298237

Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stenting.

Salvatore Cassese1, Robert A Byrne1, Stephanie Schulz1, Petra Hoppman2, Johanna Kreutzer1, Antonia Feuchtenberger1, Tareq Ibrahim2, Ilka Ott1, Massimiliano Fusaro1, Heribert Schunkert1, Karl-Ludwig Laugwitz2, Adnan Kastrati3.   

Abstract

AIM: Routine control angiography is a valuable tool with high-sensitivity in detecting restenosis after coronary stenting. However, the prognostic role of restenosis is still controversial. We investigated the impact of restenosis on 4-year mortality in patients undergoing routine control angiography after coronary stenting. METHODS AND
RESULTS: All the patients undergoing successful implantation of coronary stents for de novo lesions from 1998 to 2009 and routine control angiography after 6-8 months at two centres in Munich, Germany were studied. Restenosis was defined as diameter stenosis ≥50% in the in-segment area at follow-up angiography. The primary outcome was 4-year mortality. The study included 10 004 patients with 15 004 treated lesions. Restenosis was detected in 2643 (26.4%) patients. Overall, there were 702 deaths during the follow-up. Of these, 218 deaths occurred among patients with restenosis and 484 deaths occurred among patients without restenosis [unadjusted hazard ratio: HR: 1.19; (95% confidence interval CI: 1.02-1.40); P = 0.03]. The Cox proportional hazards model adjusting for other variables identified restenosis as an independent correlate of 4-year mortality [HR: 1.23; (95% CI: 1.03-1.46); P = 0.02]. Other independent correlates of 4-year mortality were age [for each 10-year increase, HR: 2.34; (95% CI: 2.12-2.60); P < 0.001], diabetes mellitus [HR: 1.68; (95% CI: 1.41-1.99); P < 0.001], current smoking habit [HR: 1.39; (95% CI: 1.09-1.76); P = 0.01], and left ventricular ejection fraction [for each 5% decrease, HR: 1.39; (95% CI: 1.31-1.48); P < 0.001].
CONCLUSIONS: In this large cohort of patients, the presence of restenosis at follow-up angiography after coronary stenting was predictive of 4-year mortality. Whether routine control angiography after coronary stenting is beneficial and influences outcomes should be evaluated by properly designed randomized trials. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Angiography; Coronary artery disease; Mortality; Restenosis

Mesh:

Year:  2014        PMID: 25298237     DOI: 10.1093/eurheartj/ehu383

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  21 in total

1.  Interventional cardiology: Restenosis predictive of 4-year mortality after stenting.

Authors:  Tim Geach
Journal:  Nat Rev Cardiol       Date:  2014-10-28       Impact factor: 32.419

Review 2.  Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment.

Authors:  Dario Buccheri; Davide Piraino; Giuseppe Andolina; Bernardo Cortese
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

3.  Follow-up tests and outcomes for patients undergoing percutaneous coronary intervention: analysis of a Japanese administrative database.

Authors:  Tomotsugu Seki; Masato Takeuchi; Ryusuke Miki; Koji Kawakami
Journal:  Heart Vessels       Date:  2018-07-14       Impact factor: 2.037

Review 4.  Percutaneous coronary intervention: balloons, stents and scaffolds.

Authors:  Roisin Colleran; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2018-07-23       Impact factor: 5.460

Review 5.  Routine Angiographic Follow-Up After Coronary Artery Disease Revascularization: Is Seeing Believing?

Authors:  Harsh Agrawal; Mohamed Teleb; Saba Lahsaei; Luis Carbajal; Ruben Montanez; Joseph P Carrozza
Journal:  Curr Cardiol Rep       Date:  2018-03-06       Impact factor: 2.931

6.  Novel treatments for in-stent restenosis: sirolimus-eluting balloons enter the arena.

Authors:  Raffaele Piccolo; Tullio Niglio; Anna Franzone; Bruno Trimarco; Giovanni Esposito
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

7.  [Choosing wisely together with the patient].

Authors:  U R Fölsch; G Hasenfuß
Journal:  Internist (Berl)       Date:  2016-06       Impact factor: 0.743

8.  A proteomic atlas of the neointima identifies novel druggable targets for preventive therapy.

Authors:  Michael Wierer; Julia Werner; Jana Wobst; Adnan Kastrati; Ganildo Cepele; Redouane Aherrahrou; Hendrik B Sager; Jeanette Erdmann; Martin Dichgans; Veit Flockerzi; Mete Civelek; Alexander Dietrich; Matthias Mann; Heribert Schunkert; Thorsten Kessler
Journal:  Eur Heart J       Date:  2021-05-07       Impact factor: 29.983

9.  Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention.

Authors:  Cheng-Ping Hu; Yu Du; Yong Zhu; Chao Shi; Zheng Qin; Ying-Xin Zhao
Journal:  Chin Med J (Engl)       Date:  2018-04-05       Impact factor: 2.628

Review 10.  Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014.

Authors:  Robert A Byrne; Michael Joner; Adnan Kastrati
Journal:  Eur Heart J       Date:  2015-09-28       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.